Stoke Therapeutics

To honor Rare Disease Week and Rare Disease Day 2025, our team created butterfly artwork to brighten a hospital’s walls as part of a project with the Foundation for Hospital Art. The butterfly symbolizes Dravet syndrome, a rare disease community we deeply support. With enthusiasm, we contributed, knowing that adding color and beauty to care environments can make a difference for patients and families.   #RareDiseaseDay2025 #StokedAboutStoke

We are passionate about making a meaningful impact for people who are living with rare diseases. As part of that, we support the EveryLife Foundation for Rare Diseases' efforts to urge the U.S. Congress to continue its support of research funding and public health resources for rare diseases.    If this is something you are passionate about, please review the petition - which will be shared with all members of Congress on Rare Disease Day - Friday, February 28.   Link to Petition: https://lnkd.in/eJgQQtyT   #RareDisease #Advocacy #RareDC2025

Today marks the start of Rare Disease Week 2025. We are proud to work together with advocates, clinicians, and families to raise awareness, educate and advocate for the needs of the rare disease community.    While individual rare diseases impact small populations, together these diseases affect ~300 million people around the world. An estimated 70% of rare genetic diseases begin in childhood. At Stoke, we are focused on improving outcomes for patients with Dravet syndrome, a rare genetic epilepsy associated with refractory seizures and neurodevelopmental impairments.   #RareDisease #RareDC2025 

We have entered into a collaboration with Biogen to develop and commercialize our potential first-in-class disease modifying medicine for the treatment of Dravet syndrome in all territories outside the United States, Canada, and Mexico. Learn more about today’s news: https://lnkd.in/ejRM5Cut

Today we celebrate International Day of Women and Girls in Science and honor the women at Stoke who have loved science as long as they can remember. Thank you for using your passion for science to make a difference in the lives of people living with severe diseases.   #WomenInScience #StokedAboutStoke

On this International Epilepsy Day, we honor the journey of the families we know and those we have yet to meet. We are proud to support today’s effort to raise awareness and gather stories from the community. It has been our privilege to invite families living with rare genetic epilepsies to our offices. Learning about their journey has taught us that epilepsy is about more than just seizures, and reminds us of the importance of our work to develop disease-modifying therapies that will make a real difference for patients. #MyEpilepsyJourney #EpilepsyDay

Stoke was proud to participate in the Rare Advocate Development (RAD) Brain Workshop in New York City this week. Thank you to the organizers, Rare Epilepsy Network (REN), Global Genes, and Mahzi Therapeutics for convening dedicated thought leaders in the rare epilepsy space to empower patient advocates as they work diligently to advance therapeutic options.

Don’t miss CEO Edward M. Kaye, MD take the stage at #JPM2025. Tune in live or watch the replay to learn more about our entry to late-stage development in Dravet syndrome and future potential for the company's platform to address additional diseases of the CNS and the eye. https://lnkd.in/e_hPvpfw

Stoke Therapeutics CEO, Edward M. Kaye, MD, is scheduled to present at #JPM2025 on Wednesday, January 15.     Save the date to join the live audio webcast or access the replay afterward: https://lnkd.in/e_hPvpfw   #Biotech #Healthcare #JPM25